The addition of durvalumab and bevacizumab to transarterial chemoembolization may improve progression-free survival in unresectable hepatocellular carcinoma.
The combination of adagrasib and cetuximab may show clinical activity and promising survival outcomes in patients with metastatic, heavily pretreated, KRAS G12C–mutated colorectal cancer.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.
Adjuvant therapy may be underutilized in patients with clinical T2N0 rectal adenocarcinoma, according to new findings presented at Digestive Disease Week 2024.
In his ASCRS 2025 presentation titled "AI Scribing and Telephone Management," Robert T. Chang, MD, shared his insights about how artificial intelligence has impacted his practice and how it can help other practices to be more efficient.